These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32295116)

  • 1. Eliminating Cervical Cancer in Mali and Senegal, Two Sub-Saharan Countries: Insights and Optimizing Solutions.
    Haque A; Kouriba B; Aïssatou N; Pant A
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32295116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning for human papillomavirus (HPV) vaccination in sub-Saharan Africa: a modeling-based approach.
    Tracy JK; Schluterman NH; Greene C; Sow SO; Gaff HD
    Vaccine; 2014 May; 32(26):3316-22. PubMed ID: 24731734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.
    De Groot AS; Tounkara K; Rochas M; Beseme S; Yekta S; Diallo FS; Tracy JK; Teguete I; Koita OA
    PLoS One; 2017; 12(2):e0171631. PubMed ID: 28192460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination.
    Black E; Richmond R
    Vaccines (Basel); 2018 Sep; 6(3):. PubMed ID: 30205561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
    Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.
    Kutz JM; Rausche P; Gheit T; Puradiredja DI; Fusco D
    BMC Public Health; 2023 May; 23(1):974. PubMed ID: 37237329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing cancer with vaccines: progress in the global control of cancer.
    Kane MA
    Cancer Prev Res (Phila); 2012 Jan; 5(1):24-9. PubMed ID: 22219163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
    Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
    Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study of cervical cancer prevention in two sub-Saharan African countries: Rwanda and Sierra Leone.
    Bangura MS; Zhao Y; Gonzalez Mendez MJ; Wang Y; Didier Sama S; Xu K; Ren R; Ma L; Qiao YL
    Front Med (Lausanne); 2022; 9():928685. PubMed ID: 36186799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS; de Sanjose S; Mayaud P
    Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Our Daughters-Ourselves: Evaluating the Impact of Paired Cervical Cancer Screening of Mothers with HPV Vaccination for Daughters to Improve HPV Vaccine Coverage in Bamako, Mali.
    Crippin T; Tounkara K; Munir H; Squibb E; Piotrowski C; Koita OA; Teguété I; De Groot AS
    Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340049
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.